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ABSTRACT
Objective: At present, toxicological tests are resource-intensive, time-consuming and require a large pool of animal models for toxicity assessment. To speed up the toxicity evaluation and to reduce animal suffering during toxicity assessment, the use of alternative methods including computational models is in high demand. The computational toxicity prediction methods are very helpful for the regulatory bodies to quickly assess the health impact of nanomaterial materials. In the present work, we have examined the mechanism of zinc oxide nanoparticle (ZnO-NP)-proteins interaction and their effect of surface chemistries of ZnO-NP on the bioactive conformation of chemokines and other cytological proteins using in silico molecular docking approaches.
Methods: Molecular docking study was conducted using AutoDock 4.0 version and the visualization result using Discover Studio 4.0.
Results: In the present study, we observed that ZnO-NP has high binding affinity with the mitogen-activated protein kinases (P-38), nuclear 
factor kappa-light-chain-enhancer of activated B cell (NF-kB) proteins, and matrix metallopeptidase-9 with docking energies −8.81, −7.64, and 
−7.27 Kcal/Mol, respectively, involving with hydrogen, metal acceptor, and electrostatic interaction. The top interacting amino acid residues with ZnO-NP are GLY, PHE, ARG, ASP, GLN, and ASN.
Conclusion: Thus, based on the molecular docking studies, we determine that the ZnO-NP is strongly interacting with the chemokines and other cytological proteins thus responsible for blocking of the activation stimuli for these proteins to initiate the biological signals for the proper functioning. We have also extracted the information of interaction pattern of ZnO-NP with the surface-enriched amino acid residues of chemokine and cytological proteins using molecular docking approach.
Keywords: Zinc oxide nanoparticle, Molecular docking, Nanoparticle-protein interaction, Toxicity.
INTRODUCTIONNanomaterials are of great interest because of their novel properties, 
including a large specific surface area and high reaction activity [1,2]. In current scenario, expansion in nanotechnology engineering has increased the prompt development of many applications for nanomaterials such as metal nanoparticles (NP) (e.g., gold and silver), 
metal oxide NP (e.g., CuO, TiO2, and zinc oxide NP [ZnO]), C60 fullerenes 
nanocrystals, and carbon nanotubes (CNTs) [3-6]. In case of NP, the diverse materials were found, for example, gold, silica, titanium, CNTs, zinc, and quantum dots have shown unique mechanisms of proteins modifications, lipid peroxidation, and DNA fragmentation reactive oxygen species possible that lead to cellular damage and other several 
disorders including cancer [7]. ZnO is most widely commonly utilized 
as a group of nanomaterials [8]. The progressive utilized ZnO-NPs in sunscreens, biosensors, food additives, pigments, rubber manufacture, and electronic materials. Rise concerns have also been its unintentional health, environmental impacts, and negative effects on the survival 
and growth of organisms [9]. A number of in vitro studies proved that ZnO-NPs are toxic for mammalian cells and are even more toxic than 
other nanoscale structures of metallic oxide [10,11]. The interaction of nanomaterial with proteins results in physiological changes that lead to various pathological phenotypes. However, the mechanism underlying these changes remain poorly understood. In this study, we have selected some of the chemokine and cytological proteins which were previously suggested to interact with ZnO-NP in various experimental 
settings [12-16]. It was experimentally verified that the interaction 
of ZnO-NP with ICAM-1, IL8, IL1B, P-38, and nuclear factor (NF-kB) 
induces expression of these proteins [12,17-19], similarly in case of 
CCL18 and CD35, interaction resulted in decreased expression [14,20]. The matrix metallopeptidase-9 (MMP-9) interacts with ZnO-NP which 
results in the increase enzymatic activity [14]. ZnO-NPs get absorbed systemically in the liver, adipose, and pancreas, which can elevate the 
level of zinc in the body [21]. The stimulation of oxidative stress is the 
vital part of the cytotoxicity of ZnO-NPs [22]. The major challenge in the current study is to deal with the size, density, and surface property variation of the nanomaterial because in the case of in vitro and in vivo experimental settings, these parameters were either poorly determined 
or with very broad range [23]. Furthermore, very few methods and studies are available where the toxicity of ZnO-NP was assessed using a computational method. In the case of new materials, computational toxicity prediction methods are now frequently used by regulatory bodies to quickly assess the health hazards. In the present study, we have investigated the mechanism of ZnO-NP-protein interaction and their effect of surface chemistries of ZnO-NP on the bioactive conformation of chemokines and other cytological proteins using in silico molecular docking approaches. We have selected those proteins which have already reported interaction with ZnO-NP and also well-established in the earlier works using in vitro techniques, and the in -silico results have been discussed comparatively. We have specifically investigated the effect of NP toxicity and an insight into the regularity of interaction has been attempted between NPs with specific amino acids.
METHODS
Retrieval of chemokine and other cytological proteins three-
dimensional (3D) conformationThe coordinates of selected proteins (Table 1) were obtained from 
the RCSB protein data bank (http://www.rcsb.org/pdb/home/
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i3.23384
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home.do). The protein molecules were prepared for the molecular interaction studies using the prepare protein protocols of Biovia Discovery Studio 4.0 software suit. Prepared protein protocol fixed various protein structure errors such as missing atoms in incomplete residues, missing loop regions, alternate conformations (disorder), non-standard atom names, and incorrect protonation state of titratable residues. For molecular docking studies, we defined the active sites of proteins using in silco literature, [24] and rest of active 
site of proteins were retrieved using COACH server [25]. COACH is a meta-server for the prediction of protein-ligand binding site prediction. The prediction of the active site is mainly based on two comparative methods, TM-SITE and S-SITE, which recognize ligand-
binding templates from the BioLiP protein function database [25] by binding-specific substructure and sequence profile comparisons. The assessment of the active site was done using the confidence score (C-score) that determined the accuracy of the active site 
prediction. C-score ranges 0–1, where a higher score indicates a more reliable prediction and this score is defined based on the quality of the threading alignments and the convergence of the I-TASSER’s structural assembly refinement simulations.
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Where M is the number of structure decoys in the cluster and Mtot is the total number of decoys generated during the I-TASSER simulations, RMSD is the average deviation of the decoys from the cluster centroid. Z(i) is the Z-score of the best template generated by ith threading in the seven LOMETS programs and Z0(i) is a program-specified Z-score cutoff for distinguishing between good and bad templates. The actives site residues of selected chemokine and other cytological proteins are 
shown in Fig. 1.
3D model of ZnO-NP
3D nano-system of ZnO-NP with a dimension of 1 nm was built with 
the help of build protocol of Biovia Material Studio 7.0. The NP was 
optimized using Forcite geometry optimization protocol [26]. The 
geometry optimization was done using COMPASS force field at 1NVT, 
300K for 100 ps.
Molecular docking of ZnO-NP with proteinsMolecular docking plays important part in the study the interaction of 
ligand with active site residues of the receptor [27]. Molecular docking of ZnO-NP with the chemokines and other cytological proteins were 
performed using the AutoDock4.0 [28,29]. AutoDock has been already implemented by several researchers to study numerous proteins-NP 
interactions [30-32]. Before going for molecular docking, hydrogen 
atoms were added to all target proteins. Kollman united charges and salvation parameters were added to the proteins. Gasteiger charge was added to the ZnO-NP. Grid box was set in such a manner that it will cover the active sites of chemokines and cytological proteins so that the interaction will take place on the active site of proteins. The values 
were set to 60 × 60 × 60 3 Å in X, Y, and Z-axis of the grid point. The grid 
point spacing was kept at 0.375 Å. Lamarckian Genetic Algorithm [33] and flexible docking calculations were used for the docking purpose. ZnO-NP was placed at random starting position random orientation and torsions were used. For the translation, quaternion and torsion steps were consider as default values in AutoDock. In AutoDock standard 
docking protocol for ligand docking consisted of 10 independent runs 
per ligand, considering an initial population of 50 randomly placed 
individuals, with 2.5 × 106 energy evaluations, a maximum number of 
27,000 iterations, a mutation rate of 0.02, a crossover rate of 0.80, and 
an elitism value of 1. The local search for an individual in the population 
was 0.06, using a maximum of 300 iterations per local search. After 
docking, the 10 solutions were clustered into groups with RMS 
deviations lower than 1.0 Å. The clusters were ranked by the lowest energy representative of each cluster. Discovery Studio 4.0 was used to analyze the resultant conformations for the intermolecular interactions and binding energy.
Investigate the consequence of the interaction of ZnO-NP on 
biological processesAfter molecular docking study, it is important to understand the biological processes in which these proteins were plays important role. We can comprehensive understand and actual impact of the docking in the biological system. To understand the biological impact, we have retrieved all the biological function of the proteins which were taken in the study in a form of network that interacts to accomplish a process to the level with in the cell or organism. Different biological functions of chemokines and other cytological proteins were accessed 
using PANTHER (http://pantherdb.org) (protein analysis through evolutionary relationships). Classification system was designed to classify proteins (and their genes) to facilitate high-throughput analysis.
RESULTS AND DISCUSSIONIn this study, we have taken cellular proteins into consideration for the examination of their interactions with ZnO-NP and the possible functions that can affect the physiology. All the putative targets of ZnO-NP and the active site predictions were carried out using COACH meta-server. The best active sites prediction base on the C-score of COACH meta-server 
for IL-1B and CCL-18 proteins are 0.23 and 0.26. In our docking studies, we have defined the active site of proteins to perform control docking with ZnO-NP. The best docking poses of ZnO-NP with proteins based on AutoDock binding energy were analyzed further. The best docking energy 
of ZnO-NP with P-38 (−8.81 Kcal/Mol), a total of 4 hydrogen bonds with 
GLY202, GLU203, ILE204, VAL369 and 4 electrostatic bonds formed 
with APS43, GLU203, ASP370, PHE371, and also 2 Metal Acceptor bonds 
with ASP365 and VAL369 amino acid residues which clearly indicate that the ZnO-NP strongly bind to the active site cavity. We observed the 
secondbest docking energy (−7.64 Kcal/Mol) of ZnO-NP with NF-kB 
protein, it forms 5 hydrogen bonds with ARG57, HIS67, GLY68, PRO71, 
Fig. 1: Interaction of zinc oxide nanoparticle with the activation 
site cavity of Chemokines and other cytological proteins. 
(a) p-38 protein, (b) nuclear factor-kB protein, (c) matrix 
metallopeptidase-9 protein, (d) IL-1B protein, (e) CCL-18 protein, 
(f) IL8 protein, (g) ICAM-1 protein, (h) CD-35 protein, respectively
a b
c d
e f
g h
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and SER243, 3 metal acceptor bonds with GLY55, ARG57, and HIS67 and 
1 electrostatic bond with PHE56 amino acid residues, and it also has strong binding in the active site cavity. On the other side, we observed 
least binding affinity for ZnO-NP with CCL-18 (−3.13 Kcal/Mol), whereas 
it forms only 3 hydrogen bonds and 4 metal acceptors with GLY5, ASN7, and GLN34 amino acid residues. The binding energies of other proteins, 
namely, ICAM-1, IL8, MMP-9, IL-1B, and CD-35 proteins with ZnO-NP are listed in Table 1.From the molecular docking interactions, we have extracted the key residues of proteins which play important role in the binding of ZnO-NP more efficiently GLY which is hydrophobic in nature and present 
in 1SVC, 3W8Q, 1I6J, and 1I1B proteins. The rest of key residues interacting with proteins are PHE, ARG, ASP, GLN, and ASN and their nature were given in Table 2.
The amino acids show least interaction with ZnO-NP is LYS, VAL, 
THR, TYR, TRP, and LEU. Details of molecular interactions of ZnO-NP with chemokines and other cytological proteins are provided in Supplementary Table 1 and the best interacting pose was shown in Fig. 1. The molecular docked proteins have a specific role in biological processes which can affect by the interaction with ZnO-NP. The outcome from this study clearly indicated that the ZnO-NP inhibits the process of response to a stimulus, cellular process, and biological adhesion more effectively and other processes were given in Fig. 2.
Fig. 2: Illustration of the interaction network of zinc oxide nanoparticle (ZnO-NP) with chemokines and other cytological proteins. Nodes with different colors represent various Biological functions of proteins which were inhibited by ZnO-NP. The figure legend represents the function of these proteins
Protein ICAM-1 also known as CD54 (cluster of differentiation 
54) has an important role in cell-cell signaling for stabilization of cell-cell interaction and facilitates the leukocyte endothelial 
transmigration [34,35]. The ICAM-1 plays a significant role in 
spermatogenesis due to its antagonistic effect on the tight junctions 
forming the blood test is barrier [34]. P-38 has an important function in cell-cell signaling against stress and is responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock. It is also involved in cell differentiation, apoptosis, 
and autophagy [36,37]. Similarly, NF-kB plays a very important role in several cellular functions. NF-kB controls the cellular responses as it belongs to the category of “rapid-acting” primary transcription factor, i.e., a transcription factor which was present in cells in an inactive state and does not undergo new protein synthesis to become 
activated [38,39]. Several innate and adaptive immune response genes 
are regulated by a transcription factor (NF-kB) [40-42]. Interaction of ZnO-NP with proteins might be altering the functional properties, as results may affect stabilization of cell-cell interactions. It is a newer approach to determine the ZnO-NP interaction with proteins using docking, without any surface modification of NP.
Table 1: Docking energies and bond information of ZnO-NP with chemokines and other cytological proteins
Proteins NP Energy in (Kcal/Mol) Total number of H Bond Metal acceptor Electrostatic
Pi-Cation Attractive charge
1I1B (IL-1B) ZnO-NP −3.23 3 - - 3
1GKG (CD 35) −3.92 2 1 1 -
1L6J (MMP-9) −7.27 5 2 1 1
1IL8 (IL8) −5.14 2 2 - 1
4MHE (CCL-18) −3.13 3 4 - -
1P53 (ICAM-1) −4.95 2 1 - 2
1SVC (NF-kB) −7.64 5 3 1 -
3W8Q (P-38) −8.81 4 2 1 3 
Fig. 2: Illustration of the interaction network of zinc oxide nanoparticle (ZnO-NP) with chemokines and other cytological proteins. Nodes 
with different colors represent various Biological functions of proteins which were inhibited by ZnO-NP. The figure legend represents the 
function of these proteins
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CONCLUSION
Using molecular docking as computational approaches could be adopted for the screening of all the NPs, which can bind to the target with experimental or modeled structures. A number of studies already reported that engineer NP particles (ENPs) interact with the biological macromolecules. Recent studies have shown that ENPs inhibit enzyme activity due to their interaction with the active site or 
binding directly with the substrate [43,44]. Using molecular docking studies, we conclude that the ZnO-NP is strongly interacting with the chemokines and other cytological proteins on its activation site and thus responsible for blocking of the activation stimuli for chemokines, and other cytological proteins to initiate the biological signals for 
the proper functioning of these proteins . In contrast, from the above results, it indicates the key interacting amino acid residues with ZnO-NP and their nature. Which plays important role in the interaction of ZnO-NP with proteins.
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Supplementary Table 1: Detail interaction of ZnO-NP with chemokines and other cytological proteins
Residues Distance Category Type
ZnO: Zn-P-38:GLU203:OE2 4.06365 Electrostatic Attractive charge
ZnO: Zn-P-38:ASP370:OD1 5.59144 Electrostatic Attractive charge
ZnO: Zn-P-38:ASP43:OD1 4.21727 Electrostatic Attractive charge
ZnO: O-P-38:ILE204:HN 2.25282 Hydrogen bond Conventional hydrogen bond
ZnO: O-P-38:VAL369:HN 2.10758 Hydrogen bond Conventional hydrogen bond
ZnO: O-P-38:GLY202:O 3.32089 Hydrogen bond Conventional hydrogen bond
ZnO: O-P-38:GLU203:CA 2.88581 Hydrogen bond Carbon-hydrogen bond
ZnO: Zn-P-38:VAL369:O 2.88454 Other Metal acceptor
ZnO: Zn-P-38:ASP365:O 2.9422 Other Metal acceptor
ZnO: Zn-P-38:PHE371 4.97511 Electrostatic Pi-cation
ZnO: O-NF-kB: ARG57:HH12 2.23276 Hydrogen bond Conventional hydrogen bond
ZnO: O-NF-kB: HIS67:HD1 2.87536 Hydrogen bond Conventional hydrogen bond
ZnO: O-NF-kB: SER243:HG 1.88466 Hydrogen bond Conventional hydrogen bond
ZnO: O-NF-kB: GLY68:CA 2.82779 Hydrogen bond Carbon-hydrogen bond
ZnO: O-NF-kB: PRO71:CD 3.2695 Hydrogen bond Carbon-hydrogen bond
ZnO: Zn-NF-kB: GLY55:O 2.04267 Other Metal acceptor
ZnO: Zn-NF-kB: HIS67:O 1.8762 Other Metal acceptor
ZnO: Zn-NF-kB: ARG57:O 2.67725 Other Metal acceptor
ZnO: Zn-NF-kB: PHE56 2.96504 Electrostatic Pi-cation
ZnO: Zn-ICAM-1: GLU425:OE2 4.49948 Electrostatic Attractive charge
ZnO: Zn-ICAM-1:GLU425:OE2 4.83506 Electrostatic Attractive charge
ZnO: O-ICAM-1:TRP380:HN 2.57444 Hydrogen bond Conventional hydrogen bond
ZnO: O-ICAM-1:ASN446:O 3.17571 Hydrogen bond Conventional hydrogen bond
ZnO: Zn-ICAM-1:ASN446:O 3.3466 Other Metal-acceptor
ZnO: O-CCL18:ASN7:HD22 2.02907 Hydrogen bond Conventional hydrogen bond
ZnO: O-CCL18:GLN34:HE22 2.3415 Hydrogen bond Conventional hydrogen bond
ZnO: O-CCL18:GLY5:O 2.60665 Hydrogen bond Conventional hydrogen bond
ZnO: Zn-CCL18:ASN7:OD1 1.96232 Other Metal acceptor
ZnO: Zn-CCL18:GLY5:O 2.53086 Other Metal acceptor
ZnO: Zn-CCL18:GLN34:O 2.40398 Other Metal acceptor
ZnO: Zn-MMP-9:ASP185:OD1 4.16553 Electrostatic Attractive charge
ZnO: O-MMP-9:GLN391:HN 2.28783 Hydrogen bond Conventional hydrogen bond
ZnO: O-MMP-9:GLY213:O 3.06005 Hydrogen bond Conventional hydrogen bond
ZnO: O-MMP-9:TYR423:OH 2.92205 Hydrogen bond Conventional hydrogen bond
ZnO: O-MMP-9:ASP390:OD2 3.18349 Hydrogen bond Conventional hydrogen bond
ZnO: O-MMP-9:ARG424:CA 2.614 Hydrogen bond Carbon-hydrogen bond
ZnO: Zn-MMP-9:GLY392:O 2.4448 Other Metal acceptor
ZnO: Zn-MMP-9:PHE425:O 2.19957 Other Metal acceptorZnO: Zn-MMP-9:TYR393 4.06398 Electrostatic Pi-cation
ZnO: O-IL8:ASN56:HD22 2.09676 Hydrogen bond Conventional hydrogen bond
ZnO: O-IL8:ARG60:HH21 2.35651 Hydrogen bond Conventional hydrogen bond
ZnO: Zn-IL8:ASN56:O 2.28737 Other Metal acceptor
ZnO: Zn-IL8:GLN59:OE1 1.77352 Other Metal acceptor
ZnO: O-CD35: HIS1012:HD2 2.17824 Hydrogen bond Carbon-hydrogen bond
ZnO: O-CD35: PRO1017:HD2 1.9715 Hydrogen bond Carbon-hydrogen bond
ZnO: Zn-CD35: THR1015:O 2.35972 Other Metal acceptor
ZnO: Zn-CD35: HIS1012 2.08723 Electrostatic Pi-cation
ZnO: Zn-IL1B: ASP76:OD1 5.15809 Electrostatic Attractive charge
ZnO: Zn-IL1B: ASP76:OD1 5.07859 Electrostatic Attractive charge
Zn0: Zn-IL1B: ASP76:OD1 5.46359 Electrostatic Attractive charge
ZnO: O-IL1B: LEU73:HN 0.465623 Hydrogen bond Conventional hydrogen bond
ZnO: O-IL1B: ASP75:HN 2.70242 Hydrogen bond Conventional hydrogen bond
ZnO: O-IL1B: LYS74:CA 1.48856 Hydrogen bond Carbon-hydrogen bond
